Drug Shortage Report for MYLAN-VERAPAMIL SR

Last updated on 2020-06-17 History
Report ID 30729
Drug Identification Number 02450496
Brand name MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL SR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) VERAPAMIL HYDROCHLORIDE
Strength(s) 240MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100BT, 500BT
ATC code C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-10-15
Actual start date 2018-10-15
Estimated end date 2020-06-16
Actual end date 2020-06-16
Shortage status Resolved
Updated date 2020-06-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v40 2018-01-31 English Compare
v39 2018-01-29 French Compare
v38 2018-01-29 English Compare
v37 2018-01-29 English Compare
v36 2018-01-26 French Compare
v35 2018-01-26 English Compare
v34 2018-01-24 French Compare
v33 2018-01-24 English Compare
v32 2018-01-19 French Compare
v31 2018-01-19 English Compare
v30 2018-01-17 French Compare
v29 2018-01-17 English Compare
v28 2018-01-12 French Compare
v27 2018-01-12 English Compare
v26 2018-01-10 French Compare
v25 2018-01-10 English Compare
v24 2018-01-08 French Compare
v23 2018-01-08 English Compare
v22 2018-01-05 French Compare
v21 2018-01-05 English Compare

Showing 61 to 80 of 100